InvestorsHub Logo
Followers 25
Posts 1616
Boards Moderated 1
Alias Born 05/02/2014

Re: Hypi post# 21315

Friday, 02/03/2017 11:23:16 AM

Friday, February 03, 2017 11:23:16 AM

Post# of 32022
Its a Ultra-marathon.

MannKind just needs to be able to stay in the race. It's hard when you need more capital to fund the marketing effort. While management intends to try and go it alone they probably be better off selling to the company to a partner who can really commercialize the product.

We know the product is truly a game changer for diabetic treatment. Its not getting positioned for formulary additions to plans as illustrated below.



With a short(four days) week last week scripts were up a bit.

Rx for week ending 1/27/17

NRx 146

TRx 267

TRx $ 196,000

MannKind begins sales training for the newly hired and existing reps next week February 6 - 10, 2017 I guess only time will tell if we can move forward.

We just have to hope the company can follow their what to expect in 2017 slide as presented at JPM in January 2017.




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News